Lung Cancer Recurrence: <sup>18</sup>F-FDG PET/CT in Clinical Practice.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31361525.
- Also identified by DOI 10.2214/AJR.19.21227.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this article is to summarize the clinical utility of <sup>18</sup>F-FDG PET/CT in the evaluation of lung cancer recurrence with an emphasis on typical anatomic and metabolic patterns of recurrence, expected posttherapeutic changes, and common pitfalls of FDG PET/CT. FDG PET/CT is useful in assessing therapeutic response and in determining the extent of recurrent disease and provides a guide for targeted biopsy. FDG PET/CT plays a crucial role in the evaluation of therapeutic response in lung cancer and guides management.
Medical subject headings
- Lung Neoplasms
- Neoplasm Recurrence, Local
- Positron Emission Tomography Computed Tomography